Join the brightest minds in Quality this October in Cork for a complimentary morning of insight, innovation and networking. With speakers from the HPRA and LifeScience industry, you’ll want a seat! 1st October Maryborough Hotel, Cork 9am to 1pm Light refreshements To register email registration@qaresources.com. Feel free to pass registration details onto your colleagues
The pharmaceutical industry has never been more global. Active pharmaceutical ingredients may be manufactured in one country, processed in another, packaged elsewhere and ultimately supplied to multiple markets. Yet while pharmaceutical supply chains continue to become more interconnected, the regulatory environments governing them do not always move at the same speed. International initiatives such
Facility expansions and new line start-ups are often seen as positive milestones for pharmaceutical companies. They may signal growth, increased capacity, new product introductions, improved technology or a stronger market position. However, from a Quality Assurance perspective, they also represent periods of heightened risk. When a new manufacturing area, packaging line, laboratory, warehouse space,
The pharmaceutical factory is changing. For decades, quality decisions were often made after the event: after a batch record was reviewed, after laboratory results were returned, after a deviation was raised, or after a trend was identified during periodic review. Today, the growth of connected manufacturing systems, automated process controls, electronic batch records, manufacturing
